OAKLAND, Calif., March 4, 2021 — Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous disorders, today announced the appointment of Ali Bauerlein to its Board of Directors.
Ms. Bauerlein brings more than 20 years of experience in the medical technology space as the CFO and co-founder of Inogen, Inc. (INGN), a leading respiratory technology provider. “I am honored to help the Koya Medical team in their mission to improve the lives of patients suffering from chronic lymphedema and venous diseases,” said Ms. Bauerlein. “I believe Koya can be a leader in this market with their patient-driven design and innovative technology.”
“We are excited to have a seasoned leader in medical innovations and home health join our team,” said Andy Doraiswamy, PhD, CEO, Koya Medical. “Ali is an experienced executive with a strong history…